返回
Akeso, Inc.（9926.HK）價格
9926.HK 股價走勢圖
AKESO (9926.HK)
Akeso, Inc.
HK$121
-1.06%
$-1.29
休市： Jan 16, 16:00:00 HKT
關鍵數據
前收市價
$121.9
開盤價
$122.3
當日範圍
$118.6 - $122.5
52週區間
$55.65 - $179
交易量
5.1M
平均成交量
6.6M
每股盈餘 (TTM)
-1.07
股息收益率
--
市值
$111.4B
什麼是 AKESO？
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
